The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on human health and the environment”. Key findings include:

* The transition towards safer and more sustainable chemicals is progressing in some areas but just getting started in others

* Action by authorities and industry has supported minimising and controlling the risks from several groups of hazardous chemicals. Efforts are ongoing to increase knowledge on chemical hazards and support risk management action where needed

* There has been little evidence of progress towards eliminating substances of concern from waste and secondary materials. This is a barrier to the transition towards a more circular economy

* Emissions of certain chemicals to water and air have fallen following specific EU regulations and international actions, but further measures are needed to reach concentration levels that are not harmful for human health and the environment. Emissions from industry still lead to major damage to both

* Human biomonitoring offers the opportunity to understand exposure to chemicals from multiple sources and thus health risks associated with chemical pollution. As such, it forms a key tool to measure the effectiveness of chemicals legislation

The report established that the use of the most harmful chemicals (in carcinogenic, mutagenic and reprotoxic (CMR) chemicals) is still growing albeit slower than the overall market. More needs to be done to avoid the use of substances of concern and to implement the principles of the safe and sustainable by design (SSbD) framework. The shift in that direction must be accelerated.

Reference:

https://www.specchemonline.com/more-work-needed-safety-sustainability

More News
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: 2-Cyanoethyl tetraisopropylphosphorodiamidite
Products in focus · 20/01/2026

Phosphorodiamidites are a unique class of phosphorus-based compounds characterized by one P–O bond and two P–N moieties. 2-Cyanoethyl tetraisopropylphosphorodiamidite plays a crucial role in solid-phase oligonucleotide synthesis. Beyond their application as synthetic precursors for oligonucleotides, phosphorodiamidites have also been reported as valuable starting materials for the synthesis of industrially relevant polymers and flame-resistant materials, including adhesives, coatings, and laminates.

In focus: Ferric Maltol
Products in focus · 13/01/2026

Ferric maltol is an oral iron complex composed of ferric iron (Fe³⁺) chelated with maltol, designed to improve iron absorption while reducing common gastrointestinal side effects associated with traditional iron salts. It is primarily used in the management of iron deficiency with better tolerability.

The 10th Biologics Festival India 2026 is a major life sciences conference focused on advancing vaccine and biologics development for emerging markets.
Events · 01/01/2026

Meet the ExSyn team at Biologics Festival India 2025
February 10 – 11, 2026
Hyatt Regency, Pune, India